GlassScriptPhysician profile
Nicholas Steven Mirkopoulos
NPI 1922007558
$655.92
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $118 · 2021: $109 · 2022: $314.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $294.14 | 2022 | |
| Ferring Pharmaceuticals INC. | $123.08 | 2020-2021 | |
| Pacira Therapeutics, INC. | $102.96 | 2019-2020 | |
| Depuy Synthes Sales INC. | $43.40 | 2020 | |
| Dynasplint Systems INC. | $27.88 | 2020 | |
| Heron Therapeutics, INC. | $19.81 | 2022 | |
| Smith+Nephew, INC. | $19.79 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mirkopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.